树突状细胞
肿瘤微环境
癌症研究
细胞生物学
获得性免疫系统
滤泡树突状细胞
抗原提呈细胞
抗原呈递
抗原
癌细胞
作者
Yoke Seng Lee,Kristen J. Radford
标识
DOI:10.1016/bs.ircmb.2019.07.006
摘要
Cancer immunotherapy harnesses the ability of the immune system to recognize and eliminate cancer. The potent ability of dendritic cells (DCs) to initiate and regulate adaptive immune responses underpins the successful generation of anti-tumor immune responses. DCs are a heterogeneous leukocyte population comprised of distinct subsets that drive specific types of immune responses. Understanding how DCs induce tumor immune responses and the mechanisms adopted by tumors to evade DC surveillance is essential to render immunotherapies more effective. This review discusses current knowledge of the roles played by different DC subsets in human cancer and how these might be manipulated as new immunotherapeutics to improve CD8+ T cell-mediated immune responses, with a particular focus on the conventional type 1 DCs (cDC1).
科研通智能强力驱动
Strongly Powered by AbleSci AI